Ace the CRNI Challenge 2025 – Infuse Your Career with Success!

Question: 1 / 400

Which antineoplastic agent does NOT require a test dose?

Daunorubicin

Dactinomycin

Dactinomycin, the correct answer, is an antineoplastic agent that does not require a test dose prior to administration. The rationale behind this stems from the pharmacological properties and safety profile of dactinomycin.

For many chemotherapeutic agents, especially those that have a higher risk of causing allergic reactions or significant toxicity, a test dose is given to ascertain the patient's tolerance. However, dactinomycin is generally well-tolerated, and adverse reactions are not frequent enough to necessitate a test dose. Instead, monitoring the patient for immediate reactions during the first full dose is sufficient.

Other agents listed, such as daunorubicin, carmustine, and mitomycin, typically involve a test dose due to their potential for severe allergic reactions or toxicity. This precaution helps healthcare providers gauge the patient’s response and safety before administering a full therapeutic dose.

Get further explanation with Examzify DeepDiveBeta

Carmustine

Mitomycin

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy